, Association pour la Recherche contre le Cancer' (contract AO/3/5099) G Gadea, N Arsic and P Roux are supported by CNRS and INSERM. Additional information Funding Funder Grant reference number Author Centre National de la Recherche Scientifique Gilles Gadea Nikola Arsic Pierre Roux, p.5099

P. Marie, . Khoury-breast-cancer-campaign, and . Bcc,

, The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication

G. Author-contributions, N. Kf, . Ad, . Smj, . Sa et al., Acquisition of data, Analysis and interpretation of data, Drafting or revising the article; SV, CA, Acquisition of data, Analysis and interpretation of data, Contributed unpublished essential data or reagents; MdT, MC, Acquisition of data; AMT, Conception and design, Analysis and interpretation of data, Drafting or revising the article ; J-CB, PR, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article, pp.0-0001

J. Bourdon, , pp.0-0003

P. Roux,

, Ethics Human subjects: Samples were examined following Local Research Ethics Committee approval under delegated authority by the Tayside Tissue Bank (www.taysidetissuebank.org)

, References

M. Adorno, M. Cordenonsi, M. Montagner, S. Dupont, C. Wong et al., A Mutant-p53/Smad Complex Opposes p63 to Empower TGF??-Induced Metastasis, Cell, vol.137, issue.1, pp.87-98, 2009.
DOI : 10.1016/j.cell.2009.01.039

M. Aoubala, F. Murray-zmijewski, M. Khoury, K. Fernandes, S. Perrier et al., p53 directly transactivates ??133p53??, regulating cell fate outcome in response to DNA damage, Cell Death & Differentiation, vol.101, issue.2, pp.248-258, 2011.
DOI : 10.1016/0027-5107(93)90162-9

URL : https://hal.archives-ouvertes.fr/inserm-00840976

N. Arsic, N. Bendris, M. Peter, C. Begon-pescia, C. Rebouissou et al., A novel function for Cyclin A2: Control of cell invasion via RhoA signaling, The Journal of Cell Biology, vol.113, issue.1, pp.147-162, 2012.
DOI : 10.1074/jbc.M406082200

URL : https://hal.archives-ouvertes.fr/hal-00714616

N. Arsic, G. Gadea, E. Lagerqvist, M. Busson, N. Cahuzac et al., The p53 isoform D133p53b promotes cancer stem cell potential, Stem Cell Reports, vol.4, p.25754205, 2015.

H. Bernard, B. Garmy-susini, N. Ainaoui, L. Van-den-berghe, A. Peurichard et al., The p53 isoform, ??133p53??, stimulates angiogenesis and tumour progression, Oncogene, vol.122, issue.17, pp.2150-2160, 2013.
DOI : 10.1002/ijc.23313

URL : https://hal.archives-ouvertes.fr/inserm-00714607

H. Bloom and W. Richardson, Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years, British Journal of Cancer, vol.11, p.13499785, 1957.

J. Bourdon, K. Fernandes, F. Murray-zmijewski, G. Liu, A. Diot et al., p53 isoforms can regulate p53 transcriptional activity, Genes & Development, vol.19, issue.18, pp.2122-2137, 2005.
DOI : 10.1101/gad.1339905

J. Bourdon, M. Khoury, A. Diot, L. Baker, K. Fernandes et al., p53 mutant breast cancer patients expressing p53g have as good a prognosis as wild-type p53 breast cancer patients, Breast Cancer Research, vol.13, pp.10-1186, 2011.

R. Brosh and V. Rotter, When mutants gain new powers: news from the mutant p53 field, Nature Reviews Cancer, vol.276, issue.10, pp.701-713, 2009.
DOI : 10.7326/0003-4819-71-4-747

S. Camus, S. Mé-nendez, K. Fernandes, N. Kua, G. Liu et al., The p53 isoforms are differentially modified by Mdm2, Cell Cycle, vol.8, issue.8, pp.1646-1655, 2012.
DOI : 10.1038/nprot.2009.128

W. De-roock, B. Biesmans, D. Schutter, J. Tejpar, and S. , Clinical Biomarkers in Oncology, Molecular Diagnosis & Therapy, vol.15, issue.14, pp.103-114, 2009.
DOI : 10.1158/1078-0432.CCR-08-2961

S. Detre, S. Jotti, G. Dowsett, and M. , A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas., Journal of Clinical Pathology, vol.48, issue.9, pp.876-878, 1995.
DOI : 10.1136/jcp.48.9.876

P. Do, L. Varanasi, S. Fan, C. Li, I. Kubacka et al., Mutant p53 cooperates with ETS2 to promote etoposide resistance, Genes & Development, vol.26, issue.8, pp.830-845, 2012.
DOI : 10.1101/gad.181685.111

P. Dong, M. Tada, J. Hamada, A. Nakamura, T. Moriuchi et al., p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells, Clinical & Experimental Metastasis, vol.23, issue.6, pp.471-483, 2007.
DOI : 10.1128/MCB.14.3.1815

P. Friedl and K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms, Nature Reviews Cancer, vol.3, issue.5, pp.362-374, 2003.
DOI : 10.1038/nrc1075

G. Gadea, M. De-toledo, C. Anguille, and P. Roux, Loss of p53 promotes RhoA???ROCK-dependent cell migration and invasion in 3D matrices, The Journal of Cell Biology, vol.11, issue.1, pp.17606-864, 2007.
DOI : 10.1083/jcb.150.4.797

G. Gadea, L. Roger, C. Anguille, M. De-toledo, V. Gire et al., TNF?? induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation, Journal of Cell Science, vol.117, issue.26, pp.6355-6364, 2004.
DOI : 10.1242/jcs.01566

G. Gadé-a, L. Lapasset, C. Gauthier-rouviè-re, and P. Roux, Regulation of Cdc42-mediated morphological effects: a novel function for p53, The EMBO Journal, vol.21, issue.10, pp.2373-2382, 2002.
DOI : 10.1093/emboj/21.10.2373

A. Goldhirsch, E. Winer, A. Coates, R. Gelber, M. Piccart-gebhart et al., Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013, Annals of Oncology, vol.360, issue.Supp 1, pp.2206-2223
DOI : 10.1056/NEJMoa0810266

R. Hewitt, A. Mcmarlin, D. Kleiner, R. Wersto, P. Martin et al., Validation of a model of colon cancer progression, 9999<::AID-PATH775>3.0.CO;2-K, pp.446-454, 2000.
DOI : 10.1038/bjc.1995.55

J. Jackson, V. Pant, Q. Li, L. Chang, A. Quintá-s-cardama et al., p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer, Cancer Cell, vol.21, issue.6, pp.793-806
DOI : 10.1016/j.ccr.2012.04.027

D. Jenkins, Y. Hornig, Y. Oei, J. Dusich, and T. Purchio, Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivodetection of mammary tumors and multiple metastases in immune deficient mice, Breast Cancer Research, vol.2, issue.4, pp.444-454, 2005.
DOI : 10.1038/sj.neo.7900079

S. Joruiz and J. Bourdon, 2016. p53 Isoforms: Key regulators of the cell fate decision. Cold Spring Harbor Perspectives in Medicine 6:a026039, p.26801896

E. Kalo, Y. Buganim, K. Shapira, H. Besserglick, N. Goldfinger et al., Mutant p53 Attenuates the SMAD-Dependent Transforming Growth Factor ??1 (TGF-??1) Signaling Pathway by Repressing the Expression of TGF-?? Receptor Type II, Molecular and Cellular Biology, vol.27, issue.23, pp.8228-8242, 2007.
DOI : 10.1128/MCB.00374-07

, Research article Cancer Biology

M. Khoury, V. Marcel, K. Fernandes, A. Diot, D. Lane et al., Detecting and Quantifying p53 Isoforms at mRNA Level in Cell Lines and Tissues, Methods in Molecular Biology, vol.962, pp.1-14, 2013.
DOI : 10.1007/978-1-62703-236-0_1

F. Kruiswijk, C. Labuschagne, and K. Vousden, p53 in survival, death and metabolic health: a lifeguard with a licence to kill, Nature Reviews Molecular Cell Biology, vol.520, issue.7, pp.393-405
DOI : 10.1038/nature14344

G. Lang, T. Iwakuma, Y. Suh, G. Liu, V. Rao et al., Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome, Cell, vol.119, issue.6, pp.861-872, 2004.
DOI : 10.1016/j.cell.2004.11.006

T. Li, N. Kon, L. Jiang, M. Tan, T. Ludwig et al., Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence, Cell, vol.149, issue.6, pp.1269-1283, 2012.
DOI : 10.1016/j.cell.2012.04.026

V. Marcel, K. Fernandes, O. Terrier, D. Lane, and J. Bourdon, Modulation of p53?? and p53?? expression by regulating the alternative splicing of TP53 gene modifies cellular response, Cell Death & Differentiation, vol.25, issue.9, pp.1377-1387, 2014.
DOI : 10.1006/meth.2001.1262

V. Marcel, M. Khoury, K. Fernandes, A. Diot, D. Lane et al., Detecting p53 Isoforms at Protein Level, Methods in Molecular Biology, vol.962, pp.15-29, 2013.
DOI : 10.1007/978-1-62703-236-0_2

V. Marcel, S. Perrier, M. Aoubala, S. Ageorges, M. Groves et al., ??160p53 is a novel N-terminal p53 isoform encoded by ??133p53 transcript, FEBS Letters, vol.17, issue.21, pp.4463-4468, 2010.
DOI : 10.1248/bpb.17.586

O. Mcdonald, H. Wu, W. Timp, A. Doi, and A. Feinberg, Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition, Nature Structural & Molecular Biology, vol.18, issue.8, pp.867-874, 2011.
DOI : 10.1016/j.ymeth.2006.07.030

D. Meek, Regulation of the p53 response and its relationship to cancer, Biochemical Journal, vol.469, issue.3, pp.325-346, 2015.
DOI : 10.1042/BJ20150517

H. Moore, L. Jordan, S. Bray, L. Baker, P. Quinlan et al., The RNA helicase p68 modulates expression and function of the ??133 isoform(s) of p53 and is inversely associated with ??133p53 expression in breast cancer, Oncogene, vol.8, issue.49, pp.6475-6484, 2010.
DOI : 10.1128/MCB.19.8.5363

P. Muller, P. Caswell, B. Doyle, M. Iwanicki, E. Tan et al., Mutant p53 Drives Invasion by Promoting Integrin Recycling, Cell, vol.139, issue.7, pp.1327-1341, 2009.
DOI : 10.1016/j.cell.2009.11.026

P. Muller, K. Vousden, and J. Norman, p53 and its mutants in tumor cell migration and invasion, The Journal of Cell Biology, vol.119, issue.2, p.21263025, 2011.
DOI : 10.1101/gad.827700

M. Oren and V. Rotter, Mutant p53 Gain-of-Function in Cancer, Cold Spring Harbor Perspectives in Biology, vol.2, issue.2, p.20182618, 2010.
DOI : 10.1101/cshperspect.a001107

A. Petitjean, M. Achatz, A. Borresen-dale, P. Hainaut, and M. Olivier, TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes, Oncogene, vol.47, issue.15, pp.2157-2165, 2007.
DOI : 10.1158/1078-0432.CCR-05-0507

C. Purdie, L. Jordan, J. Mccullough, S. Edwards, J. Cunningham et al., HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma, Histopathology, vol.13, issue.6, pp.702-707, 2010.
DOI : 10.1111/j.1365-2559.2010.03533.x

L. Roger, L. Jullien, V. Gire, and P. Roux, Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells, Journal of Cell Science, vol.123, issue.8, pp.1295-1305, 2010.
DOI : 10.1242/jcs.061002

URL : https://hal.archives-ouvertes.fr/hal-00481004

I. Roth, H. Campbell, C. Rubio, C. Vennin, M. Wilson et al., The ??133p53 isoform and its mouse analogue ??122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2, Oncogene, vol.29, issue.38, pp.4981-4989, 2016.
DOI : 10.1038/onc.2009.482

H. Smith, P. Marra, and C. Marshall, uPAR promotes formation of the p130Cas???Crk complex to activate Rac through DOCK180, The Journal of Cell Biology, vol.84, issue.4, pp.777-790, 2008.
DOI : 10.1083/jcb.200304065

T. Soussi, p53 alterations in human cancer: more questions than answers, Oncogene, vol.10, issue.15, pp.2145-2156, 2007.
DOI : 10.1006/jmbi.1999.3174

M. Suvà, N. Riggi, and B. Bernstein, Epigenetic Reprogramming in Cancer, Science, vol.12, issue.2, pp.1567-1570, 2013.
DOI : 10.1056/NEJMoa1008433

Y. Tang, I. Horikawa, M. Ajiro, A. Robles, K. Fujita et al., Downregulation of splicing factor SRSF3 induces p53??, an alternatively spliced isoform of p53 that promotes cellular senescence, Oncogene, vol.17, issue.22, pp.2792-2798, 2013.
DOI : 10.1128/JVI.01719-08

O. Terrier, V. Marcel, G. Cartet, D. Lane, L. B. Rosa-calatrava et al., Influenza A Viruses Control Expression of Proviral Human p53 Isoforms p53?? and ??133p53??, Journal of Virology, vol.86, issue.16, pp.8452-8460, 2012.
DOI : 10.1128/JVI.07143-11

J. Thiery, H. Acloque, R. Huang, and M. Nieto, Epithelial-Mesenchymal Transitions in Development and Disease, Cell, vol.139, issue.5, 2009.
DOI : 10.1016/j.cell.2009.11.007

S. Vinot, C. Anguille, M. De-toledo, G. Gadea, and P. Roux, Analysis of Cell Migration and Its Regulation by Rho GTPases and p53 in a Three???Dimensional Environment, Methods in Enzymology, vol.439, issue.07, pp.413-424, 2008.
DOI : 10.1016/S0076-6879(07)00429-6

URL : https://hal.archives-ouvertes.fr/hal-00347408